Sector News

China's global food push goes soggy with Weetabix

December 21, 2016
Food & Drink

China’s global push has gone a bit soggy with Weetabix. Bright Food may sell the British cereal-maker at a disappointing-looking valuation of about 1 billion pounds ($1.2 billion), Reuters says, citing three sources.

This foreign foray offers a cautionary tale: buying a business is the easy part, and Western products don’t always suit Chinese tastes.

There may be no deal – a Bright Food spokesperson denies a sale is in the works. But one at the mooted price would be a climb down. Bright Food bought a 60 percent stake in 2012 at a 1.2 billion pound valuation. And while the original purchase was at nearly 10 times EBITDA, a billion pounds now equates to more like 8 times. The whole foray looks even worse given sterling’s weakness.

At the time of the original purchase, this was the biggest foreign food deal out of China. Bright Food, owned by the Shanghai government, seemed to be heeding official calls for the country’s enterprises to “go global” via acquisitions. It has snapped up a string of other foreign businesses, including Israel dairy producer Tnuva and New Zealand’s Silver Fern Farms

But takeover targets bring their own baggage. Weetabix has faced sluggish economic growth and pricing pressures in its traditional Western markets. Its annual report referred to 2015 as “probably the most difficult period in a generation”. It is not obvious the guidance of a Chinese state-owned enterprise would be much help.

Nor did the Chinese go crazy for Weetabix. There had been optimism that the mushy texture of wheat biscuits drenched in milk might tickle mainland palates, because it is somewhat like hot rice porridge, a local breakfast staple. However, the 2015 annual report acknowledged the need to reinvigorate Weetabix’s China operations.

Bright is undeterred. It says mainland sales for Weetabix have actually doubled this year. And it recently insisted that the group’s wider “go-global strategy remains unchanged”. That is despite takeovers pushing leverage to an eye-watering 9.8 times EBITDA, according to Moody’s, which also points out little sign yet of notable profit growth or synergies at acquired businesses. Weetabix may be just one of the Bright Food buys that turns into mush.

($1 = 0.8085 pounds)

By Quentin Webb

Source: Reuters

comments closed

Related News

May 15, 2022

Blurred lines: Vitafoods Europe 2022 review

Food & Drink

Upon FoodBev Media’s return from Vitafoods 2022 – which took place from 10-12 May in Geneva, Switzerland – the team reflects on the event’s aim to bring together international nutraceutical suppliers and experts from across the globe.

May 15, 2022

Crunch time: Mondelēz to dump chewing gum to take bigger bite of chocolate and biscuits markets

Food & Drink

Following a strategic review last year, Mondelēz International is planning to sell its developed chewing gum business, which includes brands Trident and Dentyne. This is in addition to offloading its Halls cough drop brand, as the food giant focuses on generating 90% of revenue in its chocolates and biscuits businesses, including baked snacks.

May 15, 2022

Givaudan strengthens natural preservation portfolio with nitrite alternative for processed meat

Food & Drink

Givaudan has unveiled NaNino+, a patent-pending combination of plant-based ingredients and natural flavorings that can replace nitrite in processed meat. Designed with natural ingredients, it provides a lasting multi-sensorial food experience with a good taste, color and freshness.